【打印本页】 【下载PDF全文】 【HTML】 查看/发表评论下载PDF阅读器关闭

←前一篇|后一篇→

过刊浏览    高级检索

本文已被:浏览 2390次   下载 1803 本文二维码信息
码上扫一扫!
内镜下水囊扩张和肉毒毒素注射治疗贲门失弛缓症的疗效比较
周慧1,戴彦苗2,陆伦根1,罗声政1,钱月琴1,宛新建1*
0
(1. 上海交通大学医学院附属第一人民医院消化内科,上海 200080;
2.江苏省昆山市中医医院脾胃肝胆科,苏州 215300
*通信作者)
摘要:
目的评估贲门失弛缓症患者的食管动力学和临床症状,对比内镜下水囊扩张及肉毒毒素注射两种方法的疗效。方法采用前瞻性随机对照研究方法,选取临床初次确诊为原发性贲门失弛缓症的患者共80例,随机分为2组,分别接受内镜下水囊扩张和肉毒毒素注射治疗。记录患者治疗前及治疗后1周、1个月的临床症状评分和食管动力学指标,并记录随访12个月内患者的缓解率情况。结果两组患者治疗后1周、1个月的临床症状积分(总体症状、反食、吞咽困难、胸痛)和食管动力学指标(下食管括约肌静息压和松弛率、食管体部收缩幅度及顺行性收缩百分比)较治疗前均有改善(P<0.01)。治疗后1周水囊扩张组反食、吞咽困难症状积分的改善优于肉毒毒素注射组(P<0.05,P<0.01),治疗后1周和1个月水囊扩张组下食管括约肌静息压的改善优于肉毒毒素注射组(P<0.01)。术后12个月水囊扩张组和肉毒毒素注射组临床缓解率分别为73.2%和61.5%,Kaplan-Meier法分析显示术后12个月两组累积缓解率差异无统计学意义(P=0.29)。结论内镜下水囊扩张和肉毒毒素注射两种方法治疗贲门失弛缓症均有效,而且前者的治疗效果更好。
关键词:  贲门失弛缓症  水囊扩张  肉毒毒素类  食管动力学
DOI:10.3724/SP.J.1008.2012.001001
投稿时间:2012-03-17修订日期:2012-05-16
基金项目:
Endoscopic water-filled balloon dilatation and botulinum toxin injection for treatment of achalasia: a comparison of clinical effectiveness
ZHOU Hui1,DAI Yan-miao2,LU Lun-gen1,LUO Sheng-zheng1,QIAN Yue-qin1,WAN Xin-jian1*
(1. Department of Gastroenterology, First People’s Hospital of Shanghai, Shanghai Jiaotong University School of Medicine, Shanghai 200080, China;
2. Department of Gastroenterology, Kunshan Hospital of Traditional Chinese Medicine, Suzhou 215300, Jiangsu, China
*Corresponding author.)
Abstract:
ObjectiveTo compare the curative effects of water-filled balloon dilatation and botulinum toxin local injection in treatment of achalasia by evaluating the clinical symptoms and esophageal kinematics. MethodsEighty patients diagnosed as primary achalasia were randomly assigned to endoscopic water-filled balloon dilatation group and botulinum toxin group in a prospective randomized controlled trial. The clinical symptoms and esophageal kinematics of patients were evaluated before and 1 week, 1 month after therapy, and the data of remission were recorded during a follow-up of 24 months. ResultsThe clinical symptom scores (overall symptom, regurgitation of food, dysphagia and chest pain) and esophageal kinematics (the lower esophageal sphincter resting pressure and relaxation rate of lower esophageal sphincter, contracting amplitude of esophageal body and the percentage of esophageal body antegrade peristalsis) were significantly improved in both treatment groups 1 week and 1 month after therapy (P<0.01) . One week after treatment the improvements in regurgitation and dysphagia scores were greater in water-filled balloon group than those in the botulinum toxin group (P<0.05, P<0.01). The reduction in lower esophageal sphincter resting pressure was greater in water-filled balloon group than that in the botulinum toxin group 1 week and 1 month after treatment (P<0.01). After 12 months, the clinical remission rates in water-filled balloon group and botulinum toxin group were 73.2% and 61.5%, respectively; Kaplan-Meier analysis demonstrated no significant difference in the accumulated remission rates between the 2 groups(P=0.29). ConclusionBoth endoscopic water-filled balloon dilatation under endoscope and botulinum toxin local injection are effective for treatment of achalasia, with better therapeutic effect seen for water-filled balloon dilatation.
Key words:  achalasia  water-filled balloon dilation  botulinum toxins  esophagus kinematics